|
| Number of patients (n) | Percentage (%) | |
| Chemotherapy | Docetaxel-Prednisone | 59 | 70.24 |
| Weekly used of Taxol | 6 | 7.14 | |
| Estramustine acetate | 0 | 0 | |
| Abiraterone acetate | 8 | 9.5 | |
| Exclusively symptomatic treatment | 11 | 13.09 | |
| Enzalutamide | 0 | 0 | |
| Sipuleucel -T | 0 | 0 | |
| Estrogens | 0 | 0 | |
| Continuation of the previous androgen blockage treatment | 73 | 86.90 | |
| Adjuvant therapy | Biphosphonate | 59 | 70.23 |
| Daunosumab | 0 | 0 | |
| RT Palliative | 3 | 3.57 | |